Cargando…

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy

Chagas disease and leishmaniasis are neglected tropical diseases caused by the protozoan parasites Trypanosoma cruzi and Leishmania spp., respectively. They are among the most important parasitic diseases, affecting millions of people worldwide, being a considerable global challenge. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santi, Ana Maria Murta, Murta, Silvane Maria Fonseca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896756/ https://www.ncbi.nlm.nih.gov/pubmed/35239945 http://dx.doi.org/10.1590/0074-02760210401

Ejemplares similares

Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets
por: Santi, Ana Maria Murta, et al.
Publicado: (2022)

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility
por: Santi, Ana Maria Murta, et al.
Publicado: (2021)

Experimental and Clinical Treatment of Chagas Disease: A Review
por: Sales Junior, Policarpo Ademar, et al.
Publicado: (2017)

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target
por: Lazarin-Bidóia, Danielle, et al.
Publicado: (2022)

The heterologous expression of Escherichia coli MutT enzyme is involved in the protection against oxidative stress in Leishmania braziliensis
por: Andrade, Laila de Carvalho, et al.
Publicado: (2020)

Ascorbate peroxidase overexpression protects Leishmania braziliensis against trivalent antimony effects
por: Moreira, Douglas de Souza, et al.
Publicado: (2018)

Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance
por: Horácio, Elvira Cynthia Alves, et al.
Publicado: (2021)

Involvement of nucleoside diphosphate kinase b and elongation factor 2 in Leishmania braziliensis antimony resistance phenotype
por: Moreira, Douglas S., et al.
Publicado: (2016)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and –susceptible Leishmania braziliensis and Leishmania infantum lines
por: Andrade, Juvana M, et al.
Publicado: (2014)

Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease
por: Waghabi, Mariana Caldas, et al.
Publicado: (2022)

Biosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Disease
por: Oppenheimer, Michelle, et al.
Publicado: (2011)

Disruption of multiple copies of the Prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi
por: Santi, Ana Maria Murta, et al.
Publicado: (2022)

Genomic surveillance: a potential shortcut for effective Chagas disease management
por: de Azevedo, Sophia Lincoln Cardoso, et al.
Publicado: (2023)

In vitro activity of 1,3-bisaryloxypropanamines against Trypanosoma cruzi-infected L929 cultures
por: Lavorato, Stefânia Neiva, et al.
Publicado: (2015)

Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
por: Silva, Ana Catarina Cristovão, et al.
Publicado: (2019)

Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice
por: Santi, Ana Maria Murta, et al.
Publicado: (2018)

Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony()
por: Moreira, Douglas S., et al.
Publicado: (2013)

Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease
por: Bautista-López, Norma L., et al.
Publicado: (2022)

Mannosyltransferase (GPI-14) overexpression protects promastigote and amastigote forms of Leishmania braziliensis against trivalent antimony
por: Ribeiro, Christiana Vargas, et al.
Publicado: (2019)

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease
por: Moraes Neto, Roberval Nascimento, et al.
Publicado: (2019)

Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
por: Souto, Eliana B., et al.
Publicado: (2019)

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
por: J, Brindha, et al.
Publicado: (2021)

Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe
por: Dujardin, Jean-Claude, et al.
Publicado: (2008)

Economic crisis and increased immigrant mobility: new challenges in managing Chagas disease in Europe
por: Jackson, Yves, et al.
Publicado: (2014)

Potential Benefits of Antioxidant Phytochemicals on Endogenous Antioxidants Defences in Chronic Diseases
por: Fratta Pasini, Anna Maria, et al.
Publicado: (2023)

Agrochemicals against Malaria, Sleeping Sickness, Leishmaniasis and Chagas Disease
por: Witschel, Matthias, et al.
Publicado: (2012)

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
por: Khare, Shilpi, et al.
Publicado: (2016)

Defence mechanisms: the role of physiology in current and future environmental protection paradigms
por: Glover, Chris N
Publicado: (2018)

Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
por: Andrade, Juvana Moreira, et al.
Publicado: (2020)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved(*)
por: Lannes-Vieira, Joseli, et al.
Publicado: (2023)

Rationally designed siRNAs without miRNA-like off-target repression
por: Seok, Heeyoung, et al.
Publicado: (2016)

Redox Systems, Oxidative Stress, and Antioxidant Defences in Health and Disease
por: Allegra, Mario
Publicado: (2021)

The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies
por: Catara, Giuliana, et al.
Publicado: (2023)

Trypanocidal Activity of Flavanone Derivatives
por: Maciel Diogo, Gabriela, et al.
Publicado: (2020)

Evolution of cubic membranes as antioxidant defence system
por: Deng, Yuru, et al.
Publicado: (2015)

Hahnemann’s Defence of the Organon of Rational Medicine: An Explanatory Commentary upon the Homœopathic System
Publicado: (1896)

Renal dysfunction in Leishmaniasis and Chagas disease coinfection: a case report
por: de Alcântara, Cid Carlos Soares, et al.
Publicado: (2018)

Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease
por: Roquero, Irene, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l6icc4viv1qgkeg98ul8si18t8